Related Experiment Video

Updated: Oct 1, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis

Bangyan Stiles1, Valeriya Gilman, Natalya Khanzenzon

  • 1Howard Hughes Medical Institute and Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, California 90095-1735, USA.

Molecular and Cellular Biology
|May 9, 2002
PubMed

Insights

The tumor suppressor PTEN is frequently mutated in cancers. This study shows that AKT-1 activation is essential for PTEN-deficient cancer cell survival and proliferation, highlighting AKT-1 as a key player in PTEN-controlled tumorigenesis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • PTEN gene mutations are common in human cancers.
  • PTEN inactivation often leads to AKT activation.
  • Previous studies linked Pten deletion in ES cells to increased PIP(3), enhanced S phase entry, and improved cell survival.

Purpose of the Study:

  • To directly assess the role of AKT-1 in PTEN-controlled cellular processes.
  • To investigate AKT-1's contribution to cell proliferation, survival, and tumorigenesis in PTEN-deficient cells.

Main Methods:

  • Mutating Akt-1 in Pten(-/-) embryonic stem (ES) cells.
  • Assessing cellular phenotypes including proliferation and survival.
  • Evaluating tumorigenesis in nude mice models.

Main Results:

  • AKT-1 was identified as a major downstream effector of PTEN in ES cells.
  • AKT-1 activation is necessary for the enhanced cell survival and proliferation in Pten(-/-) ES cells.
  • Akt-1 deletion partially reversed the aggressive in vivo growth of Pten(-/-) ES cells.

Conclusions:

  • AKT-1 plays a critical role in mediating PTEN's tumor suppressor functions.
  • Targeting AKT-1 may be a viable strategy for treating PTEN-deficient cancers.
  • Understanding the PTEN-AKT pathway is crucial for cancer therapy development.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...